Delivering meaningful impact in hematology at the 2025 ASH® Annual Meeting.
The 67th ASH Inizio® Annual Meeting and Exposition is the leading global event in hematology, bringing together researchers, clinicians, and innovators to share advances shaping the future of blood science and patient care.
At Inizio, we’re helping clients embrace hematology’s complexity – uniting deep scientific expertise, strategic insight, and seamless execution to deliver meaningful impact. Our teams support clients across the full commercialization journey, helping them anticipate change, accelerate decisions, and turn innovation into advantage.
Our experience spans the hematology landscape: we’ve partnered with 19 of the top 20 global hematology pharma companies, supported 76 assets across development and launch, and helped deliver solutions representing over half of global hematology sales.1
Visit us at booth #277 to meet our experts and explore how Inizio’s integrated expertise is driving measurable impact across hematology’s fast-evolving ecosystem.
If you’d like to meet with us at the event, please get in touch.
Reference
- Inizio Financial data (23-24) & Evaluate Pharma datasets as of Oct ’25
Jump to a slide with the slide dots.
Kristen Oeltjen-Bruns appointed President, Ashfield MedComms US
Inizio Medical is delighted to announce the appointment of Kristen Oeltjen-Bruns as President, Ashfield MedComms US, ushering in an exciting new chapt
Read moreNaseem Ahmed named Top 100 ChangeLeader 2025 by We Make Change
Recognizing purpose-driven leadership at Inizio We’re proud to announce that Naseem Ahmed, Inizio’s Global...
Read moreLeading the future of Intelligent Commercialization™: Where proprietary data, tech, and AI meet expert insight
Discover how Inizio unites AI, data, and scientific expertise to drive Intelligent Commercialization™—accelerating launches and delivering measurab...
Read more